Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels

Jutta Dierkes, Claus Luley, Sabine WestphalInstitute of Clinical Chemistry and Biochemistry, University Hospital Magdeburg, Germany Abstract: Elevated plasma concentrations of homocysteine, a sulfur-containing amino acid, are a risk factor for coronary, cerebral and peripheral artery disease. Next t...

Full description

Bibliographic Details
Main Authors: Jutta Dierkes, Claus Luley, Sabine Westphal
Format: Article
Language:English
Published: Dove Medical Press 2007-03-01
Series:Vascular Health and Risk Management
Online Access:https://www.dovepress.com/effect-of-lipid-lowering-and-anti-hypertensive-drugs-on-plasma-homocys-peer-reviewed-article-VHRM
id doaj-19915e68847c43edbed532692f7567ae
record_format Article
spelling doaj-19915e68847c43edbed532692f7567ae2020-11-24T23:06:41ZengDove Medical PressVascular Health and Risk Management1178-20482007-03-01Volume 3991081460Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levelsJutta DierkesClaus LuleySabine WestphalJutta Dierkes, Claus Luley, Sabine WestphalInstitute of Clinical Chemistry and Biochemistry, University Hospital Magdeburg, Germany Abstract: Elevated plasma concentrations of homocysteine, a sulfur-containing amino acid, are a risk factor for coronary, cerebral and peripheral artery disease. Next to other factors, drugs used for the prevention or treatment of cardiovascular disease may modulate plasma homocysteine levels. Thus, a drug induced homocysteine increase may counteract the desired cardioprotective effect. The aim is to summarize the current knowledge on the effect of two important classes of drugs, lipid-lowering drugs and anti-hypertensive drugs, on homocysteine metabolism. Among the lipid-lowering drugs, especially the fibric acid derivatives, which are used for treatment of hypertriglyceridemia and low HDL-cholesterol, are associated with an increase of homocysteine by 20%–50%. This increase can be reduced, but not totally avoided by the addition of folic acid, vitamin B12 and B6 to fibrates. HMG-CoA reductase inhibitors (statins) do not influence homocysteine concentrations substantially. The effects of nicotinic acid and n3-fatty acids on the homocysteine concentrations are less clear, more studies are necessary to clarify their influence on homocysteine. Antihypertensive drugs have also been studied with respect to homocysteine metabolism. A homocysteine increase has been shown after treatment with hydrochlorothiazide, a lowering was observed after treatment with ß-blockers, but no effect with ACE-inhibitors. The clinical significance of the homocysteine elevation by fibrates and thiazides is not clear. However, individual patients use these drugs for long time, indicating that even moderate increases may be important.Keywords: homocysteine, fibrates, diuretics, cardiovascular diseasehttps://www.dovepress.com/effect-of-lipid-lowering-and-anti-hypertensive-drugs-on-plasma-homocys-peer-reviewed-article-VHRM
collection DOAJ
language English
format Article
sources DOAJ
author Jutta Dierkes
Claus Luley
Sabine Westphal
spellingShingle Jutta Dierkes
Claus Luley
Sabine Westphal
Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
Vascular Health and Risk Management
author_facet Jutta Dierkes
Claus Luley
Sabine Westphal
author_sort Jutta Dierkes
title Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
title_short Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
title_full Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
title_fullStr Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
title_full_unstemmed Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
title_sort effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels
publisher Dove Medical Press
series Vascular Health and Risk Management
issn 1178-2048
publishDate 2007-03-01
description Jutta Dierkes, Claus Luley, Sabine WestphalInstitute of Clinical Chemistry and Biochemistry, University Hospital Magdeburg, Germany Abstract: Elevated plasma concentrations of homocysteine, a sulfur-containing amino acid, are a risk factor for coronary, cerebral and peripheral artery disease. Next to other factors, drugs used for the prevention or treatment of cardiovascular disease may modulate plasma homocysteine levels. Thus, a drug induced homocysteine increase may counteract the desired cardioprotective effect. The aim is to summarize the current knowledge on the effect of two important classes of drugs, lipid-lowering drugs and anti-hypertensive drugs, on homocysteine metabolism. Among the lipid-lowering drugs, especially the fibric acid derivatives, which are used for treatment of hypertriglyceridemia and low HDL-cholesterol, are associated with an increase of homocysteine by 20%–50%. This increase can be reduced, but not totally avoided by the addition of folic acid, vitamin B12 and B6 to fibrates. HMG-CoA reductase inhibitors (statins) do not influence homocysteine concentrations substantially. The effects of nicotinic acid and n3-fatty acids on the homocysteine concentrations are less clear, more studies are necessary to clarify their influence on homocysteine. Antihypertensive drugs have also been studied with respect to homocysteine metabolism. A homocysteine increase has been shown after treatment with hydrochlorothiazide, a lowering was observed after treatment with ß-blockers, but no effect with ACE-inhibitors. The clinical significance of the homocysteine elevation by fibrates and thiazides is not clear. However, individual patients use these drugs for long time, indicating that even moderate increases may be important.Keywords: homocysteine, fibrates, diuretics, cardiovascular disease
url https://www.dovepress.com/effect-of-lipid-lowering-and-anti-hypertensive-drugs-on-plasma-homocys-peer-reviewed-article-VHRM
work_keys_str_mv AT juttadierkes effectoflipidloweringandantihypertensivedrugsonplasmahomocysteinelevels
AT clausluley effectoflipidloweringandantihypertensivedrugsonplasmahomocysteinelevels
AT sabinewestphal effectoflipidloweringandantihypertensivedrugsonplasmahomocysteinelevels
_version_ 1725621708537200640